IRONWOOD PHARMACEUTICALS INC
IRWDNasdaq
$3.86
↓ -0.3%Jul 17 close · end-of-day
Price
1Y↑ +421.8%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$643.4M
Enterprise Value
$423.0M
P/E
6.4
P/S
1.8
P/B
—
EV/EBITDA
2.1
PEG
—
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
$361.5M
Net Income (TTM)
$102.2M
Free Cash Flow (TTM)
—
Gross Margin
—
Operating Margin
55.4%
Net Margin
28.3%
ROE
-47.0%
ROIC
—
Debt / Equity
—
Net Cash
$220.5M
Return 1Y
+388.1%
Company profile
Management & directors
- Silver RonaldPrincipal Accounting Officer
- Gaskins Tammi LChief Commercial Officer
- John MinardoChief Legal Officer
- Mccourt Thomas AChief Executive Officer
- Martini Gregory S.Chief Financial Officer
- Shetzline MichaelSVP, CMO, Head-Res&Drug
Roles derived from SEC Form 4 filings.
Earnings
IRWD Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$106.5M↑ +158.9%
Diluted EPS$0.24↓ -204.3%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $389.5M | $413.8M | $410.6M | $442.7M | $351.4M | $296.2M |
| Gross profit | — | — | — | — | — | — |
| Operating income | $142.9M | $232.3M | $250.3M | -$945.4M | $93.1M | $98.5M |
| Net income | $106.2M | $528.4M | $175.1M | -$1.0B | $880,000.00 | $24.0M |
| Diluted EPS | $0.66 | $3.21 | $0.96 | -$6.45 | $0.01 | $0.15 |
| Operating cash flow | $168.8M | $261.9M | $273.8M | $183.4M | $103.5M | $127.0M |
| Free cash flow | $167.0M | $261.6M | $273.6M | $183.2M | $103.4M | $127.0M |
| Gross margin | — | — | — | — | — | — |
| Operating margin | 36.7% | 56.1% | 61.0% | -213.5% | 26.5% | 33.3% |
| Net margin | 27.3% | 127.7% | 42.6% | -233.0% | 0.3% | 8.1% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $94.4M | $91.6M | $90.5M | $41.1M | $85.2M | $122.1M | $47.7M | $106.5M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $25.0M | $25.6M | $31.5M | -$29.1M | $45.3M | $75.5M | $6.8M | $72.6M |
| Net income | -$860,000.00 | $3.6M | $2.3M | -$37.4M | $23.6M | $40.1M | -$2.3M | $40.8M |
| Diluted EPS | -$0.01 | $0.02 | $0.01 | -$0.23 | $0.14 | $0.23 | -$0.01 | $0.24 |
| Operating cash flow | $33.5M | $9.9M | $15.2M | $20.0M | -$15.1M | $47.6M | $74.6M | $5.1M |
| Free cash flow | $33.4M | $9.9M | $15.2M | $19.9M | -$15.1M | $47.6M | $74.6M | — |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | 26.5% | 28.0% | 34.8% | -70.7% | 53.2% | 61.8% | 14.3% | 68.1% |
| Net margin | -0.9% | 4.0% | 2.5% | -90.9% | 27.7% | 32.8% | -4.8% | 38.3% |
Company news
Coming soonHeadlines for IRWD will appear here once the news feed is connected.
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-07 | Silver Ronald· PFO & PAO | Sale | 127,890 | $4.52 | $578,062.80 | filing |
| 2026-06-16 | McHugh Julie | Sale | 21,571 | $3.73 | $80,459.83 | filing |
| 2026-06-16 | Kessler Marla L | Award | 63,481 | $0.00 | $0.00 | filing |
| 2026-06-16 | Currie Mark G | Award | 63,481 | $0.00 | $0.00 | filing |
| 2026-06-16 | Duane Jon R | Award | 63,481 | $0.00 | $0.00 | filing |
| 2026-06-16 | DENNER ALEXANDER J | Award | 63,481 | $0.00 | $0.00 | filing |
| 2026-06-16 | Moukheibir Catherine | Award | 63,481 | $0.00 | $0.00 | filing |
| 2026-06-16 | McHugh Julie | Award | 63,481 | $0.00 | $0.00 | filing |
| 2026-06-16 | Shepard Jay | Award | 63,481 | $0.00 | $0.00 | filing |
| 2026-06-15 | DENNER ALEXANDER J | Award | 4,065 | $0.00 | $0.00 | filing |
| 2026-05-19 | Silver Ronald· PFO & PAO | Award | 25,000 | $0.00 | $0.00 | filing |
| 2026-03-17 | DENNER ALEXANDER J | Sale | 6,725,000 | $3.05 | $20.5M | filing |
| 2026-03-17 | DENNER ALEXANDER J | Sale | 5,800 | $3.31 | $19,198.00 | filing |
| 2026-03-13 | DENNER ALEXANDER J | Award | 4,451 | $0.00 | $0.00 | filing |
| 2026-03-10 | Shetzline Michael· SVP, CMO, Head-Res&Drug | Award | 136,612 | $0.00 | $0.00 | filing |
| 2026-03-10 | Martini Gregory S.· Chief Financial Officer | Award | 136,612 | $0.00 | $0.00 | filing |
| 2026-03-10 | Gaskins Tammi L· Chief Commercial Officer | Award | 136,612 | $0.00 | $0.00 | filing |
| 2026-03-10 | John Minardo· Chief Legal Officer | Award | 136,612 | $0.00 | $0.00 | filing |
| 2026-03-10 | Silver Ronald· Principal Accounting Officer | Award | 163,934 | $0.00 | $0.00 | filing |
| 2026-03-10 | MCCOURT Thomas A· Chief Executive Officer | Award | 409,836 | $0.00 | $0.00 | filing |
| 2026-02-24 | MCCOURT Thomas A· Chief Executive Officer | Sale | 103,526 | $3.66 | $378,905.16 | filing |
| 2026-02-24 | John Minardo· Chief Legal Officer | Sale | 19,053 | $3.66 | $69,733.98 | filing |
| 2026-02-24 | Shetzline Michael· SVP, CMO, Head-Res&Drug | Sale | 17,012 | $3.66 | $62,263.92 | filing |
| 2026-02-24 | Silver Ronald· Principal Accounting Officer | Sale | 12,621 | $3.66 | $46,192.86 | filing |
| 2026-02-24 | Martini Gregory S.· Chief Financial Officer | Sale | 11,457 | $3.66 | $41,932.62 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.